Perceived Barriers of Cervical Cancer Screening in Reunion Island and Key Levers for Improvment (FOSFORE)

Identification Des barrières au dépistage du Cancer du Col utérin à la Réunion et Des Leviers d'amélioration

FOSFORE study aims at identifying the barriers of cervical cancer screening in Reunion Island and key levers for improvment.

Study Overview

Status

Completed

Detailed Description

FOSFORE is a cross sectional KABP (Knowledge, Attitudes, Beliefs and Practices) telephone survey on cervical cancer screening from a sounding board of women aged between 25 and 65 years and living in Reunion Island.

Sample size was estimated from local datas on cervical cancer screening.

Study Type

Observational

Enrollment (Actual)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint Pierre, France, 97448
        • Centre Universitaire de La Réunion

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Telephone survey from a sounding board of women living in Reunion Island

Description

Inclusion Criteria:

  • Women aged between 25 and 65 yo
  • living in Reunion Island
  • speaking French, Creole or Shimaore language
  • able to answer phone

Exclusion Criteria:

  • history of hysterectomy
  • history of incomplete or total conisation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Type of barriers in cervical cancer screening
Time Frame: 6 months
Telephone survey with a KABP-like questionnaire
6 months
Proportion of barriers in cervical cancer screening
Time Frame: 6 months
Telephone survey with a KABP-like questionnaire
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Type of levers in cervical cancer screening
Time Frame: 6 months
Telephone survey with a KABP-like questionnaire
6 months
Proportion of levers in cervical cancer screening
Time Frame: 6 months
Telephone survey with a KABP-like questionnaire
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 20, 2017

Primary Completion (Actual)

June 30, 2017

Study Completion (Actual)

June 30, 2017

Study Registration Dates

First Submitted

September 9, 2016

First Submitted That Met QC Criteria

September 16, 2016

First Posted (Estimate)

September 20, 2016

Study Record Updates

Last Update Posted (Actual)

September 5, 2018

Last Update Submitted That Met QC Criteria

September 4, 2018

Last Verified

September 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Uterine Cervical Neoplasms

3
Subscribe